Dlbs3233 reduces inflammatory marker on kidney by increasing expression glut1 and glut2 in diabetic rats [version 1; peer review: awaiting peer review]

HIGHLIGHTS

• who: DL and colleagues from the Doctoral Program, Universitas Brawijaya, Malang, East Java, Indonesia have published the paper: DLBS3233 reduces inflammatory marker on kidney by increasing expression GLUT1 and GLUT2 in diabetic rats [version 1; peer review: awaiting peer review], in the Journal: (JOURNAL)
• what: The study showed that in the diabetic group, GLUT1 and GLUT2 were significantly lowered compared to the normal group.
• future: Following this discovery further research is required to determine other beneficial effects of this agent especially in preventing long-term complications in DM. Understanding the insulin-signalling process . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.